This winter we discussed new regulatory guidelines intended to increase transparency in Direct-to-Consumer (DTC) advertising including a proposed rule from the Centers for Medicare and Medicaid Services (CMS) that would...more
6/28/2019
/ Advertising ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Direct to Consumer Sales ,
Drug Pricing ,
Final Rules ,
Pharmaceutical Industry ,
Preemption ,
Prescription Drugs ,
Price Transparency ,
Secretary of HHS ,
Social Security Act